Bispecific Therapy in Cancer Treatment

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 90 Minutes

Overview

Immunotherapy has changed the cancer treatment landscape and the development of bispecific antibodies shows promising results in hematologic malignancies, specifically non-Hodgkin lymphoma and multiple myeloma. During this webcast, expert faculty will provide an overview of bispecific antibodies and their role in therapy, including currently approved agents and toxicity profile.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Recognize the mechanism of action and pharmacologic profiles of bispecific antibodies   
  2. Identify bispecific antibodies currently approved to treat myeloma and B-cell lymphoma    
  3. Review current evidence for bispecific antibodies and their place in treatment                                 
  4. Compare and contrast bispecific antibodies and CAR-T therapy

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
Course opens: 
01/19/2024
Course expires: 
01/19/2025
Cost:
$0.00
Rating: 
0

Faculty

Claudia Martin Diaz, PharmD, BCPS, BCOP

Claudia Martin Diaz, Pharm.D., BCPS, BCOP, is a Clinical Pharmacy Specialist in Hematology/Oncology & Bone Marrow Transplant at Miami Cancer Institute, Baptist Health South Florida Miami, Florida. She received her Bachelor’s degree in Chemistry from Saint Thomas University, and obtained her Doctor of Pharmacy degree from University of Florida Collage of Pharmacy in 2019. She completed both her PGY1 Pharmacy Residency and PGY2 Oncology Residency at Baptist Hospital of Miami and Miami Cancer Institute. Dr. Martin Diaz has a strong interest in teaching and enjoys precepting PGY1 and PGY2 pharmacy residents and students for inpatient hematology/oncology and bone marrow transplant learning experiences. She appreciates working closely with the multidisciplinary team and patient interaction. 

Alyssa Donadio, PharmD, BCPS, BCOP

Alyssa Donadio, Pharm.D., BCPS, BCOP, is an Inpatient Clinical Pharmacy Specialist specializing in Hematology and Stem Cell Transplant at Miami Cancer Institute, Baptist Health South Florida. She received her Bachelor’s degree in Biological Sciences from Cornell University, and obtained her Doctor of Pharmacy degree from Albany College of Pharmacy and Health Sciences in 2017. She completed her PGY1 Pharmacy Residency and PGY2 Oncology Residency at Baptist Hospital of Miami and Miami Cancer Institute. Dr. Donadio precepts PGY1 and PGY2 pharmacy residents and students for inpatient hematology/oncology and BMT/ stem cell transplant learning experiences. She is currently an active member of the Hematology Oncology Pharmacy Association (HOPA), American Society for Transplantation and Cellular Therapy (ASTCT), and the National Community Oncology Dispensing Association (NCODA).

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Alyssa Donadio, PharmD, BCPS, BCOP discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Claudia Martin Diaz, PharmD, BCPS, BCOP discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test and score a minimum of 70%
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above